ABCA1 p.Ser2054Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 12196520
[PubMed]
See RH et al: "Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux."
No.
Sentence
Comment
37
PCR-based mutagenesis was performed on the ABCA1 gene to create the S1042A and S2054A mutants as described previously (30).
X
ABCA1 p.Ser2054Ala 12196520:37:79
status: NEW39 The S1042A and S2054A mutations in ABCA1 were completely sequence-confirmed.
X
ABCA1 p.Ser2054Ala 12196520:39:15
status: NEW40 The S1042A mutation was isolated by XhoI/XbaI restriction digestion and moved into the S2054A clone, thereby generating a S1042A/S2054A double mutant that was also sequence-confirmed.
X
ABCA1 p.Ser2054Ala 12196520:40:87
status: NEWX
ABCA1 p.Ser2054Ala 12196520:40:129
status: NEW47 PCR-based mutagenesis was performed on the ABCA1 gene to create the S1042A and S2054A mutants as described previously (31).
X
ABCA1 p.Ser2054Ala 12196520:47:79
status: NEW56 Polyclonal cell lines were also prepared by pooling at least 500 individual colonies from 293 Flip-in cells co-transfected with pOG44 and pcDNA5/FRT-ABCA1, pcDNA5/FRT-ABCA1 S1042A, pcDNA5/ FRT-ABCA1 S2054A, or pcDNA5/FTR-ABCA1 S1042A/S2054A cDNAs and selected for hygromycin resistance as described above.
X
ABCA1 p.Ser2054Ala 12196520:56:199
status: NEWX
ABCA1 p.Ser2054Ala 12196520:56:234
status: NEW81 Pulse-chase labeling experiments were performed on polyclonal 293 Flip-in cells constitutively expressing wild-type ABCA1, S1042A, or S2054A.
X
ABCA1 p.Ser2054Ala 12196520:81:134
status: NEW94 HeLa cells were transfected with GFP-ABCA1 wild-type, S1042A, S2054A, or S1042A/S2054A as described above.
X
ABCA1 p.Ser2054Ala 12196520:94:62
status: NEWX
ABCA1 p.Ser2054Ala 12196520:94:80
status: NEW105 For each individual experiment, polyclonal cells expressing the pcDNA5/FRT wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A mutants were plated in triplicate at a density of 80,000 per well in 24 well dishes and labeled with 10 Ci per ml [3 H]choline (Amersham Biosciences) in 2 ml of DMEM with 1% fetal bovine serum for 24 h. Twenty-four h after labeling, cells were first washed with equilibration medium (DMEM containing 0.2% fatty acid-free bovine serum albumin) and then equilibrated in the same medium for 1 h.
X
ABCA1 p.Ser2054Ala 12196520:105:100
status: NEWX
ABCA1 p.Ser2054Ala 12196520:105:118
status: NEW153 The S2054A mutant reduced PKA phosphorylation of GST-ABCA1 aa 1873 to 2261 by 95% as determined by liquid scintillation counting of the excised radioactive bands (Fig. 4, left panel, compare lanes 2 and 3).
X
ABCA1 p.Ser2054Ala 12196520:153:4
status: NEW183 Polyclonal Flip-in 293 cells constitutively expressing wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A mutants were then examined for their ability to efflux phospholipid to ApoA-I (8, 13, 14).
X
ABCA1 p.Ser2054Ala 12196520:183:80
status: NEWX
ABCA1 p.Ser2054Ala 12196520:183:98
status: NEW186 Compared with wild-type ABCA1, the S2054A mutant showed a 40% decrease (p Ͻ 0.01) in ApoA-I-dependent phospholipid efflux whereas a 50% reduction (p Ͻ 0.01) was observed for the S1042A/S2054A mutant (Fig. 7D).
X
ABCA1 p.Ser2054Ala 12196520:186:35
status: NEWX
ABCA1 p.Ser2054Ala 12196520:186:197
status: NEW187 No significant difference in phospholipid efflux was observed between the S1042A mutant alone and wild-type ABCA1 cells or between the S2054A and S1042A/S2054A mutant cells (Fig. 7D).
X
ABCA1 p.Ser2054Ala 12196520:187:35
status: NEWX
ABCA1 p.Ser2054Ala 12196520:187:135
status: NEWX
ABCA1 p.Ser2054Ala 12196520:187:153
status: NEWX
ABCA1 p.Ser2054Ala 12196520:187:197
status: NEW188 Comparison among the different mutants showed that of the two individual mutations, S2054A clearly had the greatest effect on phospholipid efflux.
X
ABCA1 p.Ser2054Ala 12196520:188:84
status: NEWX
ABCA1 p.Ser2054Ala 12196520:188:135
status: NEWX
ABCA1 p.Ser2054Ala 12196520:188:153
status: NEW189 Additionally, efflux in cells expressing the combined mutant S1042A/S2054A was not significantly reduced compared with cells expressing S2054A alone, suggesting that Ser-2054 is the critical phosphorylated residue for phospholipid efflux (Fig. 7D).
X
ABCA1 p.Ser2054Ala 12196520:189:68
status: NEWX
ABCA1 p.Ser2054Ala 12196520:189:84
status: NEWX
ABCA1 p.Ser2054Ala 12196520:189:136
status: NEW193 To determine whether ABCA1 phosphorylation affects ApoA-I binding, HeLa cells transiently expressing GFP-tagged wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A were analyzed for Cy5-ApoA-I binding by dual-channel flow cytometric analysis.
X
ABCA1 p.Ser2054Ala 12196520:193:137
status: NEWX
ABCA1 p.Ser2054Ala 12196520:193:155
status: NEW194 Whereas a non-functional mutant mouse ABCA1 defined previously (33) showed loss of ApoA-I binding compared with its wild-type counterpart ABCA1 (Fig. 8, p Ͻ; 0.001; compare AG and MM), no significant difference in ApoA-I binding was observed between cells expressing wild-type human ABCA1 or any of the phosphorylation mutants (Fig. 8, compare WT, S1042A, S2054A, and S1042A/S2054A).
X
ABCA1 p.Ser2054Ala 12196520:194:137
status: NEWX
ABCA1 p.Ser2054Ala 12196520:194:155
status: NEWX
ABCA1 p.Ser2054Ala 12196520:194:361
status: NEWX
ABCA1 p.Ser2054Ala 12196520:194:380
status: NEW197 The decay constant for wild-type ABCA1 (about 3 h) was comparable with that found for either S1042A or S2054A alone (Table I).
X
ABCA1 p.Ser2054Ala 12196520:197:103
status: NEW199 Therefore, the data indicate that the reduction in ApoA-I-dependent phospholipid efflux in the S2054A mutant cells is not because of defects in ApoA-I binding or because of decreased ABCA1 protein stability.
X
ABCA1 p.Ser2054Ala 12196520:199:95
status: NEW214 A, purified GST alone, GST-ABCA1 aa 1873 to 2261 wild-type, and GST-ABCA1 aa 1873 to 2261 S2054A mutant were incubated with PKA catalytic subunit and [␥- 32 P]ATP. Proteins were resolved by SDS-PAGE, and the dried gel was autoradiographed (left panel).
X
ABCA1 p.Ser2054Ala 12196520:214:90
status: NEW259 C, 293 Flip-in cells constitutively expressing wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A proteins were lysed, and 200 g of protein was analyzed by SDS-PAGE followed by Western blotting with an anti-ABCA1 monoclonal antibody (AC10).
X
ABCA1 p.Ser2054Ala 12196520:259:72
status: NEWX
ABCA1 p.Ser2054Ala 12196520:259:90
status: NEW261 D, polyclonal cells constitutively expressing wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A were examined for total phospholipid efflux for 4 h in the presence or absence of ApoA-I as described under "Experimental Procedures."
X
ABCA1 p.Ser2054Ala 12196520:261:71
status: NEWX
ABCA1 p.Ser2054Ala 12196520:261:89
status: NEW274 ABCA1 proteins Mean half-life Ϯ S.D. h Wild-type 3.0 Ϯ 0.4 S1042A 3.5 Ϯ 0.4 S2054A 2.9 Ϯ 0.3 ings show that kinases such as PKA can modulate ABCA1 function, and identification of these signaling molecules may provide leads to novel approaches for regulation of ABCA1 activity.
X
ABCA1 p.Ser2054Ala 12196520:274:94
status: NEW154 The S2054A mutant reduced PKA phosphorylation of GST-ABCA1 aa 1873 to 2261 by 95% as determined by liquid scintillation counting of the excised radioactive bands (Fig. 4, left panel, compare lanes 2 and 3).
X
ABCA1 p.Ser2054Ala 12196520:154:4
status: NEW184 Polyclonal Flip-in 293 cells constitutively expressing wild-type ABCA1, S1042A, S2054A, or S1042A/S2054A mutants were then examined for their ability to efflux phospholipid to ApoA-I (8, 13, 14).
X
ABCA1 p.Ser2054Ala 12196520:184:80
status: NEWX
ABCA1 p.Ser2054Ala 12196520:184:98
status: NEW190 Additionally, efflux in cells expressing the combined mutant S1042A/S2054A was not significantly reduced compared with cells expressing S2054A alone, suggesting that Ser-2054 is the critical phosphorylated residue for phospholipid efflux (Fig. 7D).
X
ABCA1 p.Ser2054Ala 12196520:190:68
status: NEWX
ABCA1 p.Ser2054Ala 12196520:190:136
status: NEW195 Whereas a non-functional mutant mouse ABCA1 defined previously (33) showed loss of ApoA-I binding compared with its wild-type counterpart ABCA1 (Fig. 8, p b0d; 0.001; compare AG and MM), no significant difference in ApoA-I binding was observed between cells expressing wild-type human ABCA1 or any of the phosphorylation mutants (Fig. 8, compare WT, S1042A, S2054A, and S1042A/S2054A).
X
ABCA1 p.Ser2054Ala 12196520:195:361
status: NEWX
ABCA1 p.Ser2054Ala 12196520:195:380
status: NEW198 The decay constant for wild-type ABCA1 (about 3 h) was comparable with that found for either S1042A or S2054A alone (Table I).
X
ABCA1 p.Ser2054Ala 12196520:198:103
status: NEW200 Therefore, the data indicate that the reduction in ApoA-I-dependent phospholipid efflux in the S2054A mutant cells is not because of defects in ApoA-I binding or because of decreased ABCA1 protein stability.
X
ABCA1 p.Ser2054Ala 12196520:200:95
status: NEW